Piper Sandler Sees an 'Attractive Risk/Reward' on Abivax (ABVX) Shares
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel reiterated an Overweight rating and $42.00 price target on Abivax (NASDAQ: ABVX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
